the spring in august into the shall we have joining us from addis ababa john and kanga song director of the africa centers for disease control and prevention in abilene in italy, gloria tele, jani, professor of infectious diseases. at last, at the end of the university of rome and in london, max lawson, head of inequality policy at oxfam international won't welcome to all if i could start with gloria in italy. so why is the e u in excluding some vaccines like covey shield, which is, of course, just the variant of astrazeneca made in india. well, the question is very interesting because i really don't know exactly what, what the research apparently did the collaboration of the email a 5 to the email conversation was that the maggie factory where the vaccine is going to produce is not a perfectly adequate production of these kind of racks, you know, at least it's not been certificated in the proper way. does not like to jump in. does that suggest that the vaccines are not effective? well, this is not the truth. this is not true. that all the point is the sooner institute, which produce